Pfizer Inc. is recalling 77,100 syringes of 25% Dextrose Injection, USP 2.5 grams (250 mg/mL) (generic name: dextrose) sold under the Hospira brand. This recall was initiated because the expiration date printed on the individual syringes is incorrect, stating '1AUG2021' instead of the correct date, which may lead to the use of an expired product. If you have this medication, you should contact your healthcare provider or pharmacist for guidance and return any unused syringes to your place of purchase for a refund.
The expiration date printed on the syringes is incorrect, which could lead healthcare providers or patients to use the medication past its intended shelf life. Using expired dextrose injection may result in reduced effectiveness of the treatment or other safety concerns if the product has degraded.
Manufacturer initiated recall due to labeling error.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.